Lower price for nutrition assessment tool expands global access

PATH and Quansys Biosciences, Inc. improve access of the Q-Plex™ Human Micronutrient Array for low- and middle-income countries with a new price of US$1.43 per analyte, making it even more affordable and accessible to the countries that need it most.

AKURIO Islet Hormones multiplex assay

Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide, and proinsulin. The assay provides accurate measurements with high specificity – giving well-designed studies a fast track to scientific advances.

Q-Plex Micronutrient Array

Quansys Biosciences and global health nonprofit PATH have collaborated to build a new multiplex tool that will help to improve the health of women and children around the world. Using the test, countries and researchers can gather national data on micronutrient deficiency status and use it to implement and assess targeted interventions. Results also help leaders accurately establish the magnitude of the deficiency, identify subpopulations at greatest risk, and monitor the efficacy and progress of nutrition programs.

Q-View Imager line

To further growth and to improve performance, Quansys Biosciences is proud to launch a new instruments product line; the Q-View Imager Pro and the Q-View Imager LS. Both instruments are engineered for optimal performance with Q-Plex kits and reagents.

Quansys Biosciences & Allegheny Health Network Collaboration

Quansys Biosciences and Allegheny Health Network have collaborated in the development of a novel 4-plex panel of biomarkers to be used in the early diagnosis of esophageal cancer. Esophageal Cancer is a growing disease that although rare, often has deadly outcomes.

Quansys Biosciences – Aviir Collaboration

Quansys Biosciences and Aviir have collaborated to build a new multiplex array used for simultaneously measuring seven clinically relevant proteins in human serum samples. These proteins are used with the Aviir MIRISK VP test algorithm for early identification of cardiac health risk.